CME/CE

Guest: James Burton, DM, FRCP Guest: Emilio Sanchez, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including h...

Guest: Leonie Kraft, MD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including how to use validated tools and structu...

Guest: James Burton, DM, FRCP Guest: Lucio Manenti, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including ho...

Guest: Leonie Kraft, MD Guest: Lucio Manenti, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including how to u...

Guest: Lucio Manenti, MD, PhD Guest: Emilio Sanchez, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including h...

Guest: James Burton, DM, FRCP Guest: Emilio Sanchez, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including h...

Guest: James Burton, DM, FRCP Guest: Lucio Manenti, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including ho...

Guest: Leonie Kraft, MD Guest: Emilio Sanchez, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including how to...

Guest: James Burton, DM, FRCP Guest: Emilio Sanchez, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including h...

Guest: James Burton, DM, FRCP Guest: Emilio Sanchez, MD, PhD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including h...

Guest: Leonie Kraft, MD Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, and multidimensional impact on quality of life. Learn best practices from the experts, including how to use validated tools and structu...

Faculty: Jelena Pavlović, MD, PhD Faculty: Amaal J. Starling, MD, FAHS, FAAN This session from WHAV 2025 explores the complex interplay between hormonal changes and migraine pathophysiology in women, from menarche through menopause. Faculty review diagnostic frameworks, including ICHD-3 criteria, and emphasize menstrual migraine subtypes and the role of estrogen withdrawal. Evidence-based strategi...

Faculty: Jelena Pavlović, MD, PhD Faculty: Amaal J. Starling, MD, FAHS, FAAN This session from WHAV 2025 explores the complex interplay between hormonal changes and migraine pathophysiology in women, from menarche through menopause. Faculty review diagnostic frameworks, including ICHD-3 criteria, and emphasize menstrual migraine subtypes and the role of estrogen withdrawal. Evidence-based strategi...

Faculty: Linda Bradley, MD Faculty: Obianuju Sandra Madueke-Laveaux, MD, MPH Faculty: Lauren R. Kornegay This dynamic symposium will guide clinicians through a modern, patient-centered approach to endometriosis care. Faculty will explore how early diagnosis can improve physical and psychosocial outcomes, examine tools to advance equity and shared decision-making, and evaluate the latest evidence f...

Faculty: Gideon Hirschfield, MB, BChir, PhD Faculty: Marlyn Mayo, MD This WHAV 2025 session examines primary biliary cholangitis (PBC), a chronic autoimmune liver disease that predominantly affects women and often goes unrecognized. Tailored for clinicians who play a key role in identifying symptoms and initiating referrals, the session outlines diagnostic criteria—including AMA positivity and ele...

Host: Martin J. Abrahamson, MD, FACP, FRCP Guest: Stefano Del Prato, MD Guest: Linong Ji, MD On-demand webcast with expert faculty presentation highlighting key studies in diabetes from the 2025 American Diabetes Association and European Association for the Study of Diabetes annual meetings.

Faculty: Linda Bradley, MD Faculty: Obianuju Sandra Madueke-Laveaux, MD, MPH Faculty: Lauren R. Kornegay This dynamic symposium will guide clinicians through a modern, patient-centered approach to endometriosis care. Faculty will explore how early diagnosis can improve physical and psychosocial outcomes, examine tools to advance equity and shared decision-making, and evaluate the latest evidence f...

Faculty: Gideon Hirschfield, MB, BChir, PhD Faculty: Marlyn Mayo, MD This WHAV 2025 session examines primary biliary cholangitis (PBC), a chronic autoimmune liver disease that predominantly affects women and often goes unrecognized. Tailored for clinicians who play a key role in identifying symptoms and initiating referrals, the session outlines diagnostic criteria—including AMA positivity and ele...

Host: Martin J. Abrahamson, MD, FACP, FRCP Guest: Stefano Del Prato, MD Guest: Linong Ji, MD On-demand webcast with expert faculty presentation highlighting key studies in diabetes from the 2025 American Diabetes Association and European Association for the Study of Diabetes annual meetings.

Faculty: Kirk Campbell, MD Guest: Joshua Albright Guest: Titilayo Ilori, MBBS Host : Kirk Campbell, University of Pennsylvania Guests : Joshua Albright, Kidney Health Advocate & Titilayo Ilori, Boston University Join our host Dr. Kirk Campbell (University of Pennsylvania) as he speaks with Dr. Titilayo Ilori (Boston University) and patient advocate Joshua Albright about APOL1 screening and ear...

Faculty: Kirk Campbell, MD Faculty: Bessie Young, MPH, MD Welcome to KDIGO Conversations in Nephrology: Burden and Pathophysiology of APOL1 Kidney Disease! Join our host Dr. Kirk Campbell (University of Pennsylvania) as he speaks with Dr. Bessie Young (University of Washington) about the discovery, impact, and future of APOL1 kidney disease. This episode explores the significant burden of kidney d...

Faculty: Iacopo Olivotto, MD Faculty: Ahmad Masri, MD, MS Faculty: Pablo Garcia-Pavia, MD, PhD Faculty: Fabian Knebel, MD, PhD Faculty: Caroline Coats, MD Hypertrophic cardiomyopathy (HCM) management is being transformed by advances in diagnostics and the emergence of targeted therapies. In this program, leading international experts review challenges in early recognition, the evolving role of bet...

Faculty: Kirk Campbell, MD Guest: Joshua Albright Guest: Titilayo Ilori, MBBS Host : Kirk Campbell, University of Pennsylvania Guests : Joshua Albright, Kidney Health Advocate & Titilayo Ilori, Boston University Join our host Dr. Kirk Campbell (University of Pennsylvania) as he speaks with Dr. Titilayo Ilori (Boston University) and patient advocate Joshua Albright about APOL1 screening and ear...

Faculty: Kirk Campbell, MD Faculty: Bessie Young, MPH, MD Welcome to KDIGO Conversations in Nephrology: Burden and Pathophysiology of APOL1 Kidney Disease! Join our host Dr. Kirk Campbell (University of Pennsylvania) as he speaks with Dr. Bessie Young (University of Washington) about the discovery, impact, and future of APOL1 kidney disease. This episode explores the significant burden of kidney d...

Faculty: Iacopo Olivotto, MD Faculty: Ahmad Masri, MD, MS Faculty: Pablo Garcia-Pavia, MD, PhD Faculty: Fabian Knebel, MD, PhD Faculty: Caroline Coats, MD Hypertrophic cardiomyopathy (HCM) management is being transformed by advances in diagnostics and the emergence of targeted therapies. In this program, leading international experts review challenges in early recognition, the evolving role of bet...